Critical factors on pulmonary absorption of peptides and proteins (diffusional barrier and metabolic barrier)

被引:13
作者
Kobayashi, S
Kondo, S
Juni, K
机构
[1] HOECHST JAPAN LTD,LAB PHARMACEUT RES,KAWAGOE,SAITAMA 35011,JAPAN
[2] JOSAI UNIV,DEPT PHARMACEUT,JOSAI,JAPAN
关键词
pulmonary; absorption; metabolism; peptides; proteins;
D O I
10.1016/S0928-0987(96)00181-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The diffusional barrier and the metabolic barrier in the pulmonary absorption of peptides and proteins were investigated from (1) correlation between bioavailability and molecular weight and (2) degradation in lung homogenates, respectively. The bioavailabilities of calcitonin, insulin, epidermal growth factor, interferon-gamma (IFN-gamma), erythropoietin (EPO) and interleukin 1-receptor (IL-1R), having molecular weights ranging from 3400 to 60 000 were 18, 9.1, 59.1, 36.8, 17.8 and 6.8%, respectively, following intratracheal administration in a rat model. Our data combined with reported values for other twelve peptides and proteins showed good correlations between bioavailability and molecular weight for proteins but poor correlations for peptides. The resistances of calcitonin and insulin in the lung homogenate were remarkably lower than those of INF-gamma, EPO and IL-1R, which were hardly metabolized. The analytical results on the bioavailability, molecular weight and enzymatic degradation suggested that the dominant factors in the pulmonary absorption would be the metabolic barrier for peptides and the diffusional barrier for proteins.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 25 条
[1]  
ADJEI AL, 1992, J BIOPHARM SCI, V3, P247
[2]   PULMONARY CATABOLISM OF INTERFERONS - ALVEOLAR ABSORPTION OF I-125-LABELED HUMAN INTERFERON-ALPHA IS ACCOMPANIED BY PARTIAL LOSS OF BIOLOGICAL-ACTIVITY [J].
BOCCI, V ;
PESSINA, GP ;
PACINI, A ;
PAULESU, L ;
MUSCETTOLA, M ;
MOGENSEN, KE .
ANTIVIRAL RESEARCH, 1984, 4 (04) :211-220
[3]   THE PHARMACOKINETICS OF PULMONARY-DELIVERED INSULIN - A COMPARISON OF INTRATRACHEAL AND AEROSOL ADMINISTRATION TO THE RABBIT [J].
COLTHORPE, P ;
FARR, SJ ;
TAYLOR, G ;
SMITH, IJ ;
WYATT, D .
PHARMACEUTICAL RESEARCH, 1992, 9 (06) :764-768
[4]   THE INFLUENCE OF REGIONAL DEPOSITION ON THE PHARMACOKINETICS OF PULMONARY-DELIVERED HUMAN GROWTH-HORMONE IN RABBITS [J].
COLTHORPE, P ;
FARR, SJ ;
SMITH, IJ ;
WYATT, D ;
TAYLOR, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :356-359
[5]   PERMEABILITY OF THE RESPIRATORY-TRACT TO DIFFERENT-SIZED MACROMOLECULES AFTER INTRATRACHEAL INSTILLATION IN YOUNG AND ADULT-RATS [J].
FOLKESSON, HG ;
WESTROM, BR ;
KARLSSON, BW .
ACTA PHYSIOLOGICA SCANDINAVICA, 1990, 139 (02) :347-354
[6]   STUDY ON PULMONARY DELIVERY OF SALMON-CALCITONIN IN RATS - EFFECTS OF PROTEASE INHIBITORS AND ABSORPTION ENHANCERS [J].
KOBAYASHI, S ;
KONDO, S ;
JUNI, K .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1239-1243
[7]   PERMEABILITY OF PEPTIDES AND PROTEINS IN HUMAN CULTURED ALVEOLAR A549 CELL MONOLAYER [J].
KOBAYASHI, S ;
KONDO, S ;
JUNI, K .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1115-1119
[8]  
KOHLER D, 1993, AEROSOLS MED PRINCIP, P303
[9]   PULMONARY DELIVERY OF FREE AND LIPOSOMAL INSULIN [J].
LIU, FY ;
SHAO, ZZ ;
KILDSIG, DO ;
MITRA, AK .
PHARMACEUTICAL RESEARCH, 1993, 10 (02) :228-232
[10]   PULMONARY BIOTRANSFORMATION OF INSULIN IN RAT AND RABBIT [J].
LIU, FY ;
KILDSIG, DO ;
MITRA, AK .
LIFE SCIENCES, 1992, 51 (21) :1683-1689